← All trials
NCT05485961
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2022
- Primary completion
- Dec 31, 2028
- Completion date
- Dec 31, 2028
- First posted
- Aug 3, 2022
- Last posted
- Aug 3, 2022
- Enrollment
- 2310
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- CSL BehringLead sponsor
- CSL BehringStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.